Literature DB >> 3189038

Histamine in carcinoid syndrome.

J Gustafsen1, S Boesby, W K Man.   

Abstract

The exact etiology of carcinoid flushing remains unknown, but the symptoms are probably mediated through release of one or several humoral substances. Flushing seen in fore-gut carcinoids (gastric carcinoids) has been ascribed to excessive histamine release, whereas flushing seen in mid-gut carcinoids (ileal carcinoids) tentatively has been ascribed to excessive release of serotonin, bradykinin, substance P, substance K or eledoisin. In this study plasma histamine was measured in 8 patients with mid-gut carcinoids and carcinoid syndrome using an enzymatic isotopic method in order to evaluate histamine as the vasoactive agent in patients with ileal carcinoid tumours and carcinoid syndrome. All patients had raised plasma histamine values. In patients with mid-gut carcinoids histamine may be one of the substances mediating flushing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3189038     DOI: 10.1007/bf01969085

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum.

Authors:  R E Shaff; M A Beaven
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

2.  Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine.

Authors:  B PERNOW; H SILWER; J WALDENSTROM
Journal:  Acta Med Scand       Date:  1956-12-08

Review 3.  Pharmacologic and endocrine aspects of carcinoid syndrome.

Authors:  J A Oates; T C Butler
Journal:  Adv Pharmacol       Date:  1967

4.  Prostaglandins in amine-peptide-secreting tumours.

Authors:  M Sandler; S M Karim; E D Williams
Journal:  Lancet       Date:  1968-11-16       Impact factor: 79.321

5.  Evidence for the release of bradykinin in carcinoid syndrome.

Authors:  J A Oates; W A Pettinger; R B Doctor
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

6.  Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors.

Authors:  I Norheim; E Theodorsson-Norheim; E Brodin; K Oberg; G Lundqvist; S Rosell
Journal:  Regul Pept       Date:  1984-11

7.  Bradykinin in carcinoid syndrome.

Authors:  J Gustafsen; S Boesby; F Nielsen; J Giese
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

8.  Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin.

Authors:  L J Roberts; Z T Bloomgarden; S R Marney; D Rabin; J A Oates
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

  8 in total
  2 in total

Review 1.  Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Authors:  Jessica E Maxwell; Boris Naraev; Daniel M Halperin; Michael A Choti; Thorvardur R Halfdanarson
Journal:  Ann Surg Oncol       Date:  2022-02-14       Impact factor: 5.344

Review 2.  Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.

Authors:  Dominique Clement; John Ramage; Raj Srirajaskanthan
Journal:  J Oncol       Date:  2020-01-21       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.